HTB supplement with a focus on southern Africa produced and distributed in partnership with the Southern African HIV Clinicians’ Society.
Editor: Polly Clayden. Contributing editor: Simon Collins. ISSN 2046-9373.
Subscriptions are free.
Each issue of HTB South is circulated for comments to our medical review board.
- October/December 2014: Volume 7 Number 4 1 November 2014.
- 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 5-9 September 2014, Washington, DC 1 November 2014.
- Antiretroviral studies at ICAAC 2014: darunavir-based FDC with TAF, cobicistat, doravirine, Stribild and gel formulation PrEP 1 November 2014.
- Switch from efavirenz to rilpivirine quells CNS toxicity, improves sleep 1 November 2014.
- HIV persists in lung macrophages of people on suppressive ART 1 November 2014.
- 20th International AIDS Conference, 20-25 July 2014, Melbourne 1 November 2014.
- Update on baseline STIs in UK oral PrEP study (PROUD) 1 November 2014.
- High prevalence of COPD at baseline in START study sub-study 1 November 2014.
- Risk of CVD or type-2 diabetes according to change in BMI after starting ART 1 November 2014.
- Rosuvastatin may be partially effective in moderating residual immune activation on ART 1 November 2014.
- Reasons for loss to follow up in the Malawi Option B+ programme 1 November 2014.
- Raltegravir pharmacokinetics in pregnancy and neonates 1 November 2014.
- Efavirenz pharmacokinetics among pregnant women with and without tuberculosis coinfection 1 November 2014.
- Immunotherapy for PML: two case reports using IL-7 and experimental recombinant JCV VP1 protein therapeutic vaccination 1 November 2014.
- Kidney signal trouble worsens over 5 years in Japanese on tenofovir 1 November 2014.
- HIV reinfection has limited impact on disease progression 1 November 2014.
- Case report: Stem cell transplantation from CCR5 delta-32 homozygous donor selects for X4-tropic HIV 1 November 2014.
- Stemming the flow from HIV reservoirs with neutralising antibodies 1 November 2014.
- DSMB open report strongly supports importance of START study 1 November 2014.
- Future conferences: 2013/2014 1 November 2014.